Waldencast has announced plans to delist its shares from the Nasdaq exchange and pursue over-the-counter trading routes under a new ticker, MLKM. The decision comes as part of a strategic shift for the company, with the contemplated transition described in coverage of the release as a move that would place trading on a different market venue and under a different ticker than the company currently uses on Nasdaq.
Market participants have taken note of the development, observing that the contemplated delisting and subsequent OTC trading would mark a change in how investors access Waldencast’s equity. The news has contributed to a decline in the stock’s price action during the session, according to wire reports compiling investor reactions and price movements associated with the move. While the exact mechanics of the transition—including the timing, listing requirements, and the logistics of moving to OTC trading—are described in coverage, the core takeaway remains that trading would shift away from Nasdaq to an over-the-counter framework under the new symbol.
Background context for traders includes the broader considerations investors weigh when a company opts for OTC trading. Regulatory and liquidity factors often accompany such transitions, with OTC markets typically presenting different disclosure standards, market depth, and trading dynamics compared with a major exchange. Coverage notes that stakeholders may monitor any changes in continuously updated information, such as corporate actions, financial disclosures, or updates from the company as it proceeds through the contemplated process.
From a market-structure perspective, the move could affect liquidity and visibility for Waldencast shares. OTC trading generally offers a route for continued public access while avoiding some of the listing maintenance requirements associated with larger exchanges. The reporting on the delisting and OTC plan emphasizes that the company intends to retain a public equity listing in some form, albeit on a venue that is different from Nasdaq. Analysts and investors will likely scrutinize how the transition is executed, how the new ticker will be integrated into trading systems, and what steps the company takes to ensure orderly trading during and after the shift.
Overall, the development represents a notable shift in Waldencast’s market presence. The delisting from Nasdaq paired with plans for OTC trading under MLKM signals a strategic realignment of how investors will access and evaluate the company’s equity going forward. Market watchers will continue to monitor official disclosures for timeline updates, regulatory approvals, and any additional financial or operational information that could influence trading dynamics on the new platform.